Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)
Authors:
- Sanae NamikiSNSanae Namiki
- Makoto KawaseMKMakoto Kawase
- Shin EbaraSEShin Ebara
- Tomoyuki TatenumaTTTomoyuki Tatenuma
- Takeshi SasakiTSTakeshi Sasaki
- Yoshinori IkehataYIYoshinori Ikehata
- Akinori NakayamaANAkinori Nakayama
- Masahiro ToideMTMasahiro Toide
- Tatsuaki YonedaTYTatsuaki Yoneda
- Kazushige SakaguchiKSKazushige Sakaguchi
- Jun TeishimaJTJun Teishima
- Kazuhide MakiyamaKMKazuhide Makiyama
Open Access
Abstract
In this multicenter retrospective cohort study, we aimed to evaluate whether pelvic lymph node dissection (PLND) improved biochemical recurrence (BCR) in patients with prostate cancer (PCa) who underwent robot-assisted radical prostatectomy (RARP) in Japan. A multicenter retrospective cohort study of 3195 PCa patients undergoing RARP at nine institutions in Japan was conducted. Enrolled patients were divided into two groups: those who underwent RARP without PLND (non-PLND group) and those who underwent PLND (PLND group). The primary endpoint was biochemical recurrence-free survival (BRFS) in PCa patients who underwent PLND. We developed a propensity score analysis to reduce the effects of selection bias and potential confounding factors. Propensity score matching resulted in 1210 patients being enrolled in the study. The 2-year BRFS rate was 95.0% for all patients, 95.8% for the non-PLND group, and 94.3% for the PLND group (p = 0.855). For the all-risk group according to the National Comprehensive Cancer Network risk stratification, there were no significant differences between patients who did and did not undergo PLND. Based on the results of the log-rank study, PLND may be unnecessary for patients with PCa undergoing RARP.Keywords
This publication has 29 references indexed in Scilit:
- Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate CancerEuropean Urology, 2017
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2016
- The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancerUrologic Oncology: Seminars and Original Investigations, 2015
- More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate CancerEuropean Urology, 2015
- Anatomic Extent of Pelvic Lymph Node Dissection: Impact on Long-term Cancer-specific Outcomes in Men With Positive Lymph Nodes at Time of Radical ProstatectomyUrology, 2013
- Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive CoresEuropean Urology, 2012
- Therapeutic value of lymph node dissection at radical prostatectomy: a population‐based case‐cohort studyBJU International, 2010
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Pelvic Lymph Node Dissection in Prostate CancerEuropean Urology, 2009
- Randomized Prospective Evaluation of Extended Versus Limited Lymph Node Dissection in Patients With Clinically Localized Prostate CancerJournal of Urology, 2003